Who, What, Where, When, Why — The Lead

In a landmark move, top U.S. health insurers—including UnitedHealthcare, Aetna, and Cigna—have pledged to dramatically reform the much-criticized prior authorization process by early 2027. The goal? Ensure that 80% of electronic requests are approved in real time, provided documentation is in order. A 90-day grace period for ongoing treatment during insurance transitions will also be introduced—removing reauthorization hurdles that currently disrupt care.

This industry-wide pledge follows mounting criticism and tragic high-profile cases that exposed the human cost of administrative delays in healthcare.

Read More:

Government Rules and CMS Updates

The federal government is now stepping in to accelerate these changes.

Starting January 1, 2025, the Centers for Medicare & Medicaid Services (CMS) will enforce:

  • 7-day turnaround for standard (non-urgent) requests

  • 2-business-day deadline for urgent requests

  • Mandatory denial justifications with each refusal

  • Real-time tracking systems for request status

For private insurers, another federal rule effective in 2026 will require transparency into the volume and reasons for denied prior authorizations. However, this will not yet apply to employer-sponsored plans, which cover a large portion of the population.

At the state level, at least 10 states and Washington D.C. have passed their own mandates demanding standardized timelines, better data transparency, and public reporting on approval/denial rates.

 

Big Shifts in Drug Coverage

A major shift is also occurring in pharmacy benefit management:

  • 80+ common drugs no longer require annual reauthorization

  • Paperwork for providers is decreasing, allowing doctors more time with patients

  • Congress is pushing legislation to exempt HIV prevention medications from any prior authorization altogether

These steps aim to reduce administrative bottlenecks in prescription fulfillment, especially for high-use, low-risk medications.

How Big Is the Problem?

The current prior authorization system is undeniably bloated:

  • In Medicare Advantage, nearly 50 million prior authorization requests were filed in a single year—roughly two per enrollee

  • By contrast, traditional Medicare saw fewer than 400,000 such requests

  • 99% of all requests are eventually approved, highlighting inefficiencies

  • Physicians report serious consequences for patients, including hospitalizations, due to unnecessary delays

  • On average, a single medical practice handles 43 authorizations per week, with many hiring dedicated staff just to manage the red tape

What Insurers Have Promised

At a high-level press conference attended by HHS Secretary Robert F. Kennedy Jr. and Medicare Director Mehmet Oz, insurers laid out specific commitments:

  • Adopt a unified electronic prior authorization system

  • Approve 80% of electronic submissions in real time

  • Reduce the list of services requiring preapproval

  • Pause prior auth requirements for 90 days when patients switch plans

  • Increase transparency with easy-to-understand denial explanations and appeal guidance

Expert & Industry Reactions

The response has been a cautious mix of optimism and skepticism:

  • Rick Pollack, CEO of the American Hospital Association, welcomed the reform as “long overdue.”

  • Kaye Pestaina, VP at KFF, raised concerns about how many services actually require preapproval and whether insurers will be held accountable.

  • The American Medical Association emphasized the need for independent oversight to ensure these reforms are implemented effectively and don’t stall.

Market & Investor Takeaways

From an economic lens:

  • Health insurance stocks may face minor disruptions in profit margins tied to utilization control

  • Providers could see operational savings due to reduced administrative strain

  • Health IT vendors specializing in authorization APIs are likely to benefit from partnerships as the industry shifts to real-time digital systems

What Comes Next?

Looking forward:

  • API-based data systems are expected to roll out across insurers by 2026

  • Monitoring tools may track real-time approvals, denial rates, and appeal outcomes

  • Regulatory audits are likely if metrics fail to improve by early 2027

  • Consumer watchdogs and physician advocacy groups will continue pushing for full transparency